Literature DB >> 31595668

Myhre syndrome: A first familial recurrence and broadening of the phenotypic spectrum.

Ilse Meerschaut1,2, Aude Beyens1,3, Wouter Steyaert1, Riet De Rycke4,5,6, Katrien Bonte7, Tine De Backer8, Sandra Janssens1, Joseph Panzer9, Frank Plasschaert10, Daniël De Wolf9, Bert Callewaert1.   

Abstract

Myhre syndrome is a rare multisystem connective tissue disorder, characterized by short stature, facial dysmorphology, variable intellectual disability, skeletal abnormalities, arthropathy, cardiopathy, laryngotracheal anomalies, and stiff skin. So far, all molecularly confirmed cases harbored a de novo heterozygous gain-of-function mutation in SMAD4, encoding the SMAD4 transducer protein required for both transforming growth factor-beta and bone morphogenic proteins signaling. We report on four novel patients (one female proband and her two affected children, and one male proband) with Myhre syndrome harboring the recurrent c.1486C>T (p.Arg496Cys) mutation in SMAD4. The female proband presented with a congenital heart defect, vertebral anomalies, and facial dysmorphic features. She developed severe tracheal stenosis requiring a total laryngectomy. With assisted reproductive treatment, she gave birth to two affected children. The second proband presented with visual impairment following lensectomy in childhood, short stature, brachydactyly, stiff skin, and decreased peripheral sensitivity. Transmission electron microscopy (TEM) of the dermis shows irregular elastin cores with globular deposits and almost absent surrounding microfibrils and suggests age-related increased collagen deposition. We report on the first familial case of Myhre syndrome and illustrate the variable clinical spectrum of the disorder. Despite the primarily fibrotic nature of the disease, TEM analysis mainly indicates elastic fiber anomalies.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  (assisted) reproduction; Myhre syndrome; TEM imaging; elastinopathy; phenotypic spectrum

Year:  2019        PMID: 31595668     DOI: 10.1002/ajmg.a.61377

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  Lack of resemblance between Myhre syndrome and other "segmental progeroid" syndromes warrants restraint in applying this classification.

Authors:  Angela E Lin; Nicola Brunetti-Pierri; Bert Callewaert; Valérie Cormier-Daire; Sofia Douzgou; T Bernard Kinane; Mark E Lindsay; Lois J Starr
Journal:  Geroscience       Date:  2021-02-25       Impact factor: 7.713

2.  SMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.

Authors:  Renuka Kandhaya-Pillai; Deyin Hou; Jiaming Zhang; Xiaomeng Yang; Goli Compoginis; Takayasu Mori; Tamara Tchkonia; George M Martin; Fuki M Hisama; James L Kirkland; Junko Oshima
Journal:  Geroscience       Date:  2021-01-05       Impact factor: 7.713

Review 3.  Association of TGF-β Canonical Signaling-Related Core Genes With Aortic Aneurysms and Aortic Dissections.

Authors:  Jicheng Chen; Rong Chang
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

4.  Natural history of Myhre syndrome.

Authors:  David Dawei Yang; Marlene Rio; Caroline Michot; Nathalie Boddaert; Wael Yacoub; Nicolas Garcelon; Briac Thierry; Damien Bonnet; Sophie Rondeau; Dominique Herve; Stephanie Guey; Francois Angoulvant; Valerie Cormier-Daire
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

5.  Acromelic dysplasias: how rare musculoskeletal disorders reveal biological functions of extracellular matrix proteins.

Authors:  Sarah Stanley; Zerina Balic; Dirk Hubmacher
Journal:  Ann N Y Acad Sci       Date:  2020-09-02       Impact factor: 5.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.